122 related articles for article (PubMed ID: 8579765)
1. Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Maestri D; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1994; 7(1):1-11. PubMed ID: 8579765
[TBL] [Abstract][Full Text] [Related]
2. Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease.
Volpi R; Caffarra P; Marcato A; Scaglioni A; Maestri D; Delsignore R; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1991; 3(2):127-32. PubMed ID: 1654925
[TBL] [Abstract][Full Text] [Related]
3. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
4. Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia.
Coiro V; d'Amato L; Marchesi C; Capretti L; Volpi R; Roberti G; Cerri L; Chiodera P
Psychoneuroendocrinology; 1990; 15(5-6):463-70. PubMed ID: 2101966
[TBL] [Abstract][Full Text] [Related]
5. Different effects of baclofen on LH and cortisol responses to naloxone in normal men.
Coiro V; Volpi R; Marcato A; Bertoni P; Cavazzini U; Caffarri G; Capretti L; Rossi G; Chiodera P
Psychoneuroendocrinology; 1992 Nov; 17(6):667-71. PubMed ID: 1337607
[TBL] [Abstract][Full Text] [Related]
6. ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain.
Volpi R; Caffarra P; Boni S; Scaglioni A; Malvezzi L; Saginario A; Chiodera P; Coiro V
Neuropsychobiology; 1997; 35(2):73-8. PubMed ID: 9097297
[TBL] [Abstract][Full Text] [Related]
7. Restoration of normal gonadotropin responses to naloxone by chronic bromocriptine treatment in elderly men.
Coiro V; Volpi R; Bertoni P; Marcato A; Vourna S; Bocchi R; Bianconi L; Marchesi M; Buonanno G; Chiodera P
Horm Res; 1991; 36(1-2):36-40. PubMed ID: 1814799
[TBL] [Abstract][Full Text] [Related]
8. Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
Coiro V; Volpi R; Gramellini D; Cigarini C; Magotti MG; Caffarri G; Chiodera P
Gynecol Obstet Invest; 1997; 43(3):162-5. PubMed ID: 9127128
[TBL] [Abstract][Full Text] [Related]
9. Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Saginario A; Maestri D; Vourna S; Vescovi PP; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1993; 6(2):99-107. PubMed ID: 7509607
[TBL] [Abstract][Full Text] [Related]
10. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
[TBL] [Abstract][Full Text] [Related]
11. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
[TBL] [Abstract][Full Text] [Related]
12. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
14. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
Moreira AC; Foss MC; Iazigi N; Verissimo JM
Horm Metab Res; 1988 Apr; 20(4):230-4. PubMed ID: 2840381
[TBL] [Abstract][Full Text] [Related]
15. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
Xiao E; Xia-Zhang L; Thornell D; Shalts E; Ferin M
Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
[TBL] [Abstract][Full Text] [Related]
16. Effect of naloxone on oxytocin-induced cortisol decrease in normal men.
Coiro V; Chiodera P; Rossi G; Volpi R; Salvi M; Camellini L; Roti E
Acta Endocrinol (Copenh); 1985 Feb; 108(2):261-5. PubMed ID: 2982243
[TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
Van Vugt DA; Piercy J; Farley AE; Reid RL; Rivest S
Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
[TBL] [Abstract][Full Text] [Related]
18. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
19. Effect of captopril, an inhibitor of the converting enzyme on naloxone induced secretion of ACTH and LH in man.
Palermo M; Oliva O; Pala A; Delitala G
Horm Metab Res; 1993 Oct; 25(10):536-8. PubMed ID: 8262463
[TBL] [Abstract][Full Text] [Related]
20. Restraint inhibits luteinizing hormone and testosterone secretion in intact male rhesus macaques: effects of concurrent naloxone administration.
Norman RL; Smith CJ
Neuroendocrinology; 1992 Apr; 55(4):405-15. PubMed ID: 1314338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
